This prospective case series describes seven infants with congenital chylothorax and/or hydrops fetalis due to CCLA, all of whom were treated with either an mTOR and/or MEK inhibitor and demonstrated remarkable clinical improvement within weeks after initiation. This evidence concerns the gene MTOR and hydrops fetalis.